This project has received funding from the European Union’s 7th Framework Programme for research, technological development and demonstration under grant agreement no 611709
Subcribe to our mailing list
> Delivering value to European SMEs and entrepeneurs
Follow this project on F6S
Follow us on twitter
Loading Twitter messages...
Interview with Pablo Graiver, CEO of TrialReach
20. March 2015
TrialReach recently raised $13,5M in series B funding. Pablo says: “Think big: scalability is key. Forget about dry slides, tell a story. And be prepared: this is a
TrialReach is a marketplace that helps connect all the stakeholders in the clinical trial space in order to make it more efficient, accelerate it, and reduce the costs involved in running
those trials. This marketplace essentially is designed to connect the pharmaceutical companies and their researchers carrying out the clinical studies, with the patients that could potentially
benefit from the development of new treatments.
For the GET project Pascal Lardier interviewed Pablo Graivier, CEO of TrialReach.